Xinmu Zhang

1.9k total citations · 2 hit papers
44 papers, 1.5k citations indexed

About

Xinmu Zhang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xinmu Zhang has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Xinmu Zhang's work include High-Temperature Coating Behaviors (6 papers), Advanced ceramic materials synthesis (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Xinmu Zhang is often cited by papers focused on High-Temperature Coating Behaviors (6 papers), Advanced ceramic materials synthesis (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Xinmu Zhang collaborates with scholars based in China, United States and Finland. Xinmu Zhang's co-authors include Lei Guo, Pan Xue, Ling Wang, Yuanhao Chen, Xinhua Xu, Pengfei Lv, Xiao Yang, Hui Xin, Jiajia Yang and Fuxing Ye and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Neuroscience.

In The Last Decade

Xinmu Zhang

42 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Near‐Infrared Light‐Driven Shape‐Morphing of Programmable Anisotropic Hydrogels Enabled by MXene Nanosheets

2020 313 citations Pan Xue, Hari Krishna Bisoyi et al. Angewandte Chemie International Edition profile →
Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma

2024 43 citations Nan Zhang, Yang Xu et al. Biomarker Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xinmu Zhang China	21	373	304	267	262	193	44	1.5k
Ruijia Liu China	22	126 0.3×	281 0.9×	198 0.7×	247 0.9×	57 0.3×	128	1.5k
Xiaoqing Du China	22	172 0.5×	137 0.5×	217 0.8×	614 2.3×	230 1.2×	78	1.8k
Yanan Huang China	35	186 0.5×	249 0.8×	395 1.5×	1.1k 4.2×	170 0.9×	154	3.6k
Xiufeng Wang China	25	492 1.3×	893 2.9×	180 0.7×	454 1.7×	78 0.4×	127	2.2k
Jianing Xu China	25	307 0.8×	143 0.5×	496 1.9×	277 1.1×	46 0.2×	117	2.0k
Thomas Hübert France	29	146 0.4×	1.2k 3.8×	414 1.6×	722 2.8×	88 0.5×	128	4.0k
Lin Lü China	33	269 0.7×	805 2.6×	458 1.7×	886 3.4×	23 0.1×	142	3.5k
Jiao Chen China	27	592 1.6×	418 1.4×	328 1.2×	374 1.4×	376 1.9×	152	2.4k
Lingzhi Chen China	20	97 0.3×	262 0.9×	241 0.9×	239 0.9×	55 0.3×	110	1.4k

Countries citing papers authored by Xinmu Zhang

Since Specialization

Citations

This map shows the geographic impact of Xinmu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinmu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinmu Zhang more than expected).

Fields of papers citing papers by Xinmu Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinmu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinmu Zhang. The network helps show where Xinmu Zhang may publish in the future.

Co-authorship network of co-authors of Xinmu Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xinmu Zhang. A scholar is included among the top collaborators of Xinmu Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinmu Zhang. Xinmu Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Yao, Jing, et al.. (2024). Hypertension risk pathways in urban built environment: the case of Yuhui District, Bengbu City, China. Frontiers in Public Health. 12. 1 indexed citations

2.

Zhang, Nan, Yang Xu, Ziyu Xun, et al.. (2024). Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma. Biomarker Research. 12(1). 26–26. 43 indexed citations breakdown →

3.

Guo, Lei, Xinmu Zhang, Mingguang Liu, Shuo Yang, & Jianwei Dai. (2023). CMAS + sea salt corrosion to thermal barrier coatings. Corrosion Science. 218. 111172–111172. 39 indexed citations

4.

Li, Yanyan, Yang Yu, Mohammad Reza Loghman‐Estarki, Xinmu Zhang, & Lei Guo. (2023). Crystallization behavior of CMAS + sea salt mixture and its effect on the mixture penetration into thermal barrier coatings. Surface and Coatings Technology. 473. 130012–130012. 9 indexed citations

5.

Chao, Jiashuo, Shanshan Wang, Hao Wang, et al.. (2023). Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis. Cancer Immunology Immunotherapy. 72(11). 3717–3726. 14 indexed citations

6.

Yu, Haoran, et al.. (2023). Spatiotemporal Evolution Characteristics and Driving Factors of Water Conservation Service in Jiangxi Province from 2001 to 2020. Sustainability. 15(15). 11941–11941. 8 indexed citations

7.

Zhang, Longhao, Jingnan Xue, Nan Zhang, et al.. (2023). The efficacy and safety of bevacizumab as a salvage therapy for patients with advanced hepatocellular carcinoma targeting immune tolerance.. PubMed. 13(8). 3582–3590. 2 indexed citations

8.

Zhang, Xinmu, et al.. (2023). Dysregulation and oncogenic activities of ubiquitin specific peptidase 2a in the pathogenesis of hepatocellular carcinoma.. PubMed. 13(6). 2392–2409. 2 indexed citations

9.

Cong, Ning, Xinmu Zhang, Xiaobo Yang, et al.. (2022). Conversion therapy of stage IVb unresectable gallbladder carcinoma. HepatoBiliary Surgery and Nutrition. 11(2). 335–337. 2 indexed citations

10.

Guo, Lei, Yuan Gao, Fuxing Ye, & Xinmu Zhang. (2021). CMAS Corrosion Behavior and Protection Method of Thermal Barrier Coatings for Aeroengine. Acta Metallurgica Sinica. 57(9). 1184–1198. 35 indexed citations

11.

Xue, Pan, Hari Krishna Bisoyi, Yuanhao Chen, et al.. (2020). Near‐Infrared Light‐Driven Shape‐Morphing of Programmable Anisotropic Hydrogels Enabled by MXene Nanosheets. Angewandte Chemie. 133(7). 3432–3438. 21 indexed citations

12.

Zhang, Xinmu, Christina Nadolny, Yuan Chen, et al.. (2020). Dysregulation of bile acids increases the risk for preterm birth in pregnant women. Nature Communications. 11(1). 2111–2111. 33 indexed citations

13.

Xue, Pan, Hari Krishna Bisoyi, Yuanhao Chen, et al.. (2020). Near‐Infrared Light‐Driven Shape‐Morphing of Programmable Anisotropic Hydrogels Enabled by MXene Nanosheets. Angewandte Chemie International Edition. 60(7). 3390–3396. 313 indexed citations breakdown →

14.

Zhang, Xinmu, Xin Nie, Junyu Long, et al.. (2020). Expression of p42.3 in non-small cell lung cancer. Annals of Translational Medicine. 8(13). 819–819. 4 indexed citations

15.

Wang, Yajing, Wenchao Cao, Xinmu Zhang, & Jingheng Guo. (2018). Rate of denitrification and stoichiometry of its products in fluvo‐aquic Cambisols for sterilized and unsterilized incubations. European Journal of Soil Science. 70(3). 530–539. 4 indexed citations

16.

An, Yukun, et al.. (2018). A highly selective and reversible turn-off fluorescent chemosensor for Cu2+ based on electrospun nanofibrous membrane modified with pyrenecarboxaldehyde. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 207. 173–182. 19 indexed citations

17.

Luo, Chengliang, Yuancai Liu, Shuanhu Zhou, et al.. (2018). The multiple protective roles and molecular mechanisms of melatonin and its precursor N-acetylserotonin in targeting brain injury and liver damage and in maintaining bone health. Free Radical Biology and Medicine. 130. 215–233. 61 indexed citations

18.

Wu, Qiaofeng, Wěi Li, Yanyang Tu, et al.. (2017). Protection of melatonin in experimental models of newborn hypoxic‐ischemic brain injury through MT1 receptor. Journal of Pineal Research. 64(1). 70 indexed citations

19.

Wu, Qiong, Cheng Gao, Haochen Wang, et al.. (2017). Mdivi-1 alleviates blood-brain barrier disruption and cell death in experimental traumatic brain injury by mitigating autophagy dysfunction and mitophagy activation. The International Journal of Biochemistry & Cell Biology. 94. 44–55. 99 indexed citations

20.

Zhou, Hua, Jian Wang, Jiying Jiang, et al.. (2014). N-Acetyl-Serotonin Offers Neuroprotection through Inhibiting Mitochondrial Death Pathways and Autophagic Activation in Experimental Models of Ischemic Injury. Journal of Neuroscience. 34(8). 2967–2978. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact